Home/Filings/4/0001104659-24-035723
4//SEC Filing

Birx Deborah 4

Accession 0001104659-24-035723

CIK 0000921114other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 8:00 PM ET

Size

7.1 KB

Accession

0001104659-24-035723

Insider Transaction Report

Form 4
Period: 2024-03-14
Birx Deborah
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2024-03-14+240,000240,000 total
    Exercise: $3.38Exp: 2034-03-14Common Stock (240,000 underlying)
  • Award

    Common Stock

    2024-03-14+60,000260,000 total
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the Stock Options shall vest on March 14th of each of 2025, 2026, 2027, and 2028.

Issuer

Armata Pharmaceuticals, Inc.

CIK 0000921114

Entity typeother

Related Parties

1
  • filerCIK 0001849673

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 8:00 PM ET
Size
7.1 KB